Management of Prostate Cancer: Proapaci 60 Tablet is utilized in the treatment of prostate cancer, particularly non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer, by inhibiting androgen receptors, thereby aiding in the deceleration or cessation of cancer cell proliferation.
PROAPACI 60MG
| MRP | : |
|
| Price | : | ₹26,900.00 |
| You Save | : | ₹6,863.13 (20.33%) |
1 Bottle of 120 Tablet
Proapaci 60 Tablet is an anti-androgen medication utilized in the treatment of prostate cancer. Prostate cancer originates in the cells of the prostate gland in men. Symptoms may include difficulties with urination, pain, numbness, and more. Proapaci 60 Tablet is indicated for metastatic castration-sensitive prostate cancer as well as non-metastatic castration-resistant prostate cancer.
Proapaci 60 Tablet contains Apalutamide, which is classified as an androgen inhibitor. It functions by blocking the production of testosterone, thereby halting the growth and dissemination of cancer.
Some potential side effects of Proapaci 60 Tablet include fatigue, headaches, diarrhea, muscle aches, hot flashes, decreased appetite, and skin rashes. Typically, these side effects resolve without requiring medical intervention. It is important to take Proapaci 60 Tablet as directed by your healthcare provider.
Avoid using Proapaci 60 Tablet if you have an allergy to it. Notify your doctor prior to taking Proapaci 60 Tablet if you have any existing conditions or a history of liver or kidney disease, cardiovascular issues such as myocardial ischemia, or seizures. This medication is not recommended for children, as its safety and effectiveness have not been established. Proapaci 60 Tablet is intended solely for male patients.
